Form 8-K Homology Medicines, Inc. For: Mar 20
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Homology Medicines Inc. (FIXX) Approves 1:18 Reverse Share Split
March 20, 2024 4:10 PM EDTAs previously reported on the Current Report on Form 8-K filed on March 15, 2024, the stockholders of Homology Medicines Inc. (NASDAQ: FIXX) at a Special Meeting of Stockholders (the Homology Special Meeting) previously approved an amendment to the Restated Certificate of Incorporation of Homology to effect a reverse stock split of Homologys issued and outstanding common stock at a ratio ranging from any whole number between 1-for-10 and 1-for-30, as determined by the Homology board of directors in its discretion, subject to the Homology board of directors authority to abandon such amendment.
The Homology... More
